ORMP NT 10-Q: Late filing
Oramed Pharmaceuticals Inc.
Filed with the SEC on · accession 0001213900-26-057722
ORMP filed a NT 10-Q (nt 10-q) with the SEC on May 15, 2026. Oramed Pharmaceuticals Inc. filed a Form 12b-25 Notification of Late Filing for its quarterly report on Form 10-Q for the period ended March 31, 2026, citing the need for additional time to complete and finalize its financial statements. The stock moved -1.9% by the first close after the filing.
Summary of the filing
Oramed Pharmaceuticals Inc. filed a Form 12b-25 Notification of Late Filing for its quarterly report on Form 10-Q for the period ended March 31, 2026, citing the need for additional time to complete and finalize its financial statements. The company expects to file the report within the five-day grace period.
Key details
How ORMP stock reacted
Close before
$4.73
May 14, 2026
First close after
-1.90%
$4.64
5 trading days
-7.40%
$4.38
Since filing
-18.39%
$3.86
✦ Ask GOAX AI about this filing — what it means for ORMP, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ORMP?
Click hereFrequently asked questions
What did ORMP file with the SEC on May 15, 2026?
ORMP filed a NT 10-Q (Late filing). Oramed Pharmaceuticals Inc. filed a Form 12b-25 Notification of Late Filing for its quarterly report on Form 10-Q for the period ended March 31, 2026, citing the need for additional time to complete and finalize its financial statements. The company expects to file the report within the five-day grace period.
What does a late filing mean for ORMP stock?
The stock often falls sharply. In a Chapter 11 reorganization existing shares are frequently cancelled or heavily diluted; in Chapter 7 the company is liquidated and shareholders are paid last, usually nothing.
How do I read a NT 10-Q?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A NT 10-Q (nt 10-q): A report the company filed with the SEC (the US market regulator).
How did ORMP stock react to this filing?
ORMP closed at $4.73 before the filing and $4.64 on May 15, 2026 (-1.90%). Five trading days later: $4.38 (-7.40%).
Other ORMP SEC filings
Get alerts when ORMP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days